annual working capital:
$1.85B+$50.06M(+2.78%)Summary
- As of today (June 29, 2025), CRSP annual working capital is $1.85 billion, with the most recent change of +$50.06 million (+2.78%) on December 31, 2024.
- During the last 3 years, CRSP annual working capital has fallen by -$448.28 million (-19.51%).
- CRSP annual working capital is now -19.51% below its all-time high of $2.30 billion, reached on December 31, 2021.
Performance
CRSP Working capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly working capital:
$1.75B-$101.19M(-5.47%)Summary
- As of today (June 29, 2025), CRSP quarterly working capital is $1.75 billion, with the most recent change of -$101.19 million (-5.47%) on March 31, 2025.
- Over the past year, CRSP quarterly working capital has dropped by -$252.47 million (-12.62%).
- CRSP quarterly working capital is now -30.66% below its all-time high of $2.52 billion, reached on June 30, 2021.
Performance
CRSP quarterly working capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Working capital Formula
Working Capital = Current Assets − Current Liabilities
CRSP Working capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +2.8% | -12.6% |
| 3 y3 years | -19.5% | -18.6% |
| 5 y5 years | +98.8% | +100.0% |
CRSP Working capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -19.5% | +6.8% | -18.6% | +6.0% |
| 5 y | 5-year | -19.5% | +98.8% | -30.7% | +100.0% |
| alltime | all time | -19.5% | >+9999.0% | -30.7% | +1091.8% |
CRSP Working capital History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $1.75B(-5.5%) |
| Dec 2024 | $1.85B(+2.8%) | $1.85B(-0.3%) |
| Sep 2024 | - | $1.85B(-1.5%) |
| Jun 2024 | - | $1.88B(-5.9%) |
| Mar 2024 | - | $2.00B(+11.2%) |
| Dec 2023 | $1.80B(+3.9%) | $1.80B(+9.1%) |
| Sep 2023 | - | $1.65B(-4.5%) |
| Jun 2023 | - | $1.73B(-2.0%) |
| Mar 2023 | - | $1.76B(+1.7%) |
| Dec 2022 | $1.73B(-24.6%) | $1.73B(-2.8%) |
| Sep 2022 | - | $1.78B(-10.3%) |
| Jun 2022 | - | $1.99B(-7.4%) |
| Mar 2022 | - | $2.15B(-6.6%) |
| Dec 2021 | $2.30B(+41.6%) | $2.30B(-5.2%) |
| Sep 2021 | - | $2.42B(-3.9%) |
| Jun 2021 | - | $2.52B(+44.1%) |
| Mar 2021 | - | $1.75B(+7.8%) |
| Dec 2020 | $1.62B | $1.62B(+24.1%) |
| Sep 2020 | - | $1.31B(+46.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2020 | - | $891.11M(+1.9%) |
| Mar 2020 | - | $874.20M(-6.0%) |
| Dec 2019 | $930.44M(+112.1%) | $930.44M(+59.2%) |
| Sep 2019 | - | $584.29M(+43.5%) |
| Jun 2019 | - | $407.06M(-3.4%) |
| Mar 2019 | - | $421.40M(-3.9%) |
| Dec 2018 | $438.65M(+87.6%) | $438.65M(-5.5%) |
| Sep 2018 | - | $464.41M(+48.8%) |
| Jun 2018 | - | $312.07M(-7.4%) |
| Mar 2018 | - | $337.08M(+44.1%) |
| Dec 2017 | $233.87M(-21.6%) | $233.87M(-5.1%) |
| Sep 2017 | - | $246.47M(-7.2%) |
| Jun 2017 | - | $265.47M(-5.0%) |
| Mar 2017 | - | $279.55M(-6.3%) |
| Dec 2016 | $298.19M(+103.3%) | $298.19M(+94.2%) |
| Sep 2016 | - | $153.55M(-8.9%) |
| Jun 2016 | - | $168.56M(+14.9%) |
| Dec 2015 | $146.69M(<-9900.0%) | $146.69M |
| Dec 2014 | -$1.18M | - |
FAQ
- What is CRISPR Therapeutics AG annual working capital?
- What is the all time high annual working capital for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG annual working capital year-on-year change?
- What is CRISPR Therapeutics AG quarterly working capital?
- What is the all time high quarterly working capital for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG quarterly working capital year-on-year change?
What is CRISPR Therapeutics AG annual working capital?
The current annual working capital of CRSP is $1.85B
What is the all time high annual working capital for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high annual working capital is $2.30B
What is CRISPR Therapeutics AG annual working capital year-on-year change?
Over the past year, CRSP annual working capital has changed by +$50.06M (+2.78%)
What is CRISPR Therapeutics AG quarterly working capital?
The current quarterly working capital of CRSP is $1.75B
What is the all time high quarterly working capital for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high quarterly working capital is $2.52B
What is CRISPR Therapeutics AG quarterly working capital year-on-year change?
Over the past year, CRSP quarterly working capital has changed by -$252.47M (-12.62%)